<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://en.longevitywiki.org/wiki/Frailty/history?feed=atom</id>
	<title>Frailty - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://en.longevitywiki.org/wiki/Frailty/history?feed=atom"/>
	<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/wiki/Frailty/history"/>
	<updated>2026-04-20T12:18:18Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.41.0</generator>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3185&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Preclinical development of treatment for frailty */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3185&amp;oldid=prev"/>
		<updated>2024-03-12T15:40:10Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Preclinical development of treatment for frailty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 15:40, 12 March 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l78&quot;&gt;Line 78:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 78:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Preclinical development of treatment for frailty ====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Preclinical development of treatment for frailty ====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Some frailty treatments that have been evaluated in in vivo models for the effectiveness of &#039;&#039;&#039;alpha-ketoglutarate (AKG)&#039;&#039;&#039;,&amp;lt;ref&amp;gt;Shahmirzadi, A. A., Edgar, D., Liao, C. Y., Hsu, Y. M., Lucanic, M., Shahmirzadi, A. A., ... &amp;amp; Lithgow, G. J. (2020). Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. Cell metabolism, 32(3), 447-456. PMID: 32877690 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508957/ PMC8508957] DOI: 10.1016/j.cmet.2020.08.004&amp;lt;/ref&amp;gt; [[Isomyosamine|&#039;&#039;&#039;MyMD-1&#039;&#039;&#039;]] (&#039;&#039;&#039;Isomyosamine&#039;&#039;&#039;),&amp;lt;ref&amp;gt;[https://www.sec.gov/Archives/edgar/data/1321834/000149315222020346/ex99-1.htm The Phase 2 multi-center double-blind, placebo controlled, randomized study (NCT05283486]) investigates the efficacy, tolerability and pharmacokinetics of MYMD-1 in the treatment of chronic inflammation associated with sarcopenia/frailty in participants aged 65 years or older.&amp;lt;/ref&amp;gt; &#039;&#039;&#039;[[rapamycin]]&#039;&#039;&#039;, &#039;&#039;&#039;recombinant Sestrin 1 (rSESN1)&#039;&#039;&#039;,&amp;lt;ref&amp;gt;Jing, Y., Zuo, Y., Sun, L., Yu, Z. R., Ma, S., Hu, H., ... &amp;amp; Wang, S. (2023). SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Proliferation, e13455. PMID: 37199024 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212707/ PMC10212707] DOI: 10.1111/cpr.13455&amp;lt;/ref&amp;gt; and  an aminoindazole derivative, &#039;&#039;&#039;locamidazole (LAMZ)&#039;&#039;&#039;&amp;lt;ref&amp;gt;Ono, T., Denda, R., Tsukahara, Y., Nakamura, T., Okamoto, K., Takayanagi, H., &amp;amp; Nakashima, T. (2022). Simultaneous augmentation of muscle and bone by locomomimetism through calcium-PGC-1α signaling. Bone Research, 10(1), 52. PMID: 35918335 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345981/ PMC9345981] DOI: 10.1038/s41413-022-00225-w&amp;lt;/ref&amp;gt; show promise in counteracting frailty.&amp;lt;ref&amp;gt;Contartese, D., Di Sarno, L., Salamanna, F., Martini, L., Fini, M., Giavaresi, G., &amp;amp; Veronesi, F. (2023). Exploring In Vivo Models of Musculoskeletal Frailty: A Comprehensive Systematic Review. International Journal of Molecular Sciences, 24(23), 16948.  PMID: 38069274 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10706801/ PMC10706801] DOI: 10.3390/ijms242316948&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Some frailty treatments that have been evaluated in in vivo models for the effectiveness of &#039;&#039;&#039;alpha-ketoglutarate (AKG)&#039;&#039;&#039;,&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Naeini, S. H., Mavaddatiyan, L., Kalkhoran, Z. R., Taherkhani, S., &amp;amp; Talkhabi, M. (2023). Alpha-ketoglutarate as a potent regulator for lifespan and healthspan: Evidences and perspectives. Experimental Gerontology, 175, 112154.  PMID: 36934991 [https://doi.org/10.1016/j.exger.2023.112154 DOI: 10.1016/j.exger.2023.112154]&amp;lt;/ref&amp;gt;&lt;/ins&gt;&amp;lt;ref&amp;gt;Shahmirzadi, A. A., Edgar, D., Liao, C. Y., Hsu, Y. M., Lucanic, M., Shahmirzadi, A. A., ... &amp;amp; Lithgow, G. J. (2020). Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. Cell metabolism, 32(3), 447-456. PMID: 32877690 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508957/ PMC8508957] DOI: 10.1016/j.cmet.2020.08.004&amp;lt;/ref&amp;gt; [[Isomyosamine|&#039;&#039;&#039;MyMD-1&#039;&#039;&#039;]] (&#039;&#039;&#039;Isomyosamine&#039;&#039;&#039;),&amp;lt;ref&amp;gt;[https://www.sec.gov/Archives/edgar/data/1321834/000149315222020346/ex99-1.htm The Phase 2 multi-center double-blind, placebo controlled, randomized study (NCT05283486]) investigates the efficacy, tolerability and pharmacokinetics of MYMD-1 in the treatment of chronic inflammation associated with sarcopenia/frailty in participants aged 65 years or older.&amp;lt;/ref&amp;gt; &#039;&#039;&#039;[[rapamycin]]&#039;&#039;&#039;, &#039;&#039;&#039;recombinant Sestrin 1 (rSESN1)&#039;&#039;&#039;,&amp;lt;ref&amp;gt;Jing, Y., Zuo, Y., Sun, L., Yu, Z. R., Ma, S., Hu, H., ... &amp;amp; Wang, S. (2023). SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Proliferation, e13455. PMID: 37199024 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212707/ PMC10212707] DOI: 10.1111/cpr.13455&amp;lt;/ref&amp;gt; and  an aminoindazole derivative, &#039;&#039;&#039;locamidazole (LAMZ)&#039;&#039;&#039;&amp;lt;ref&amp;gt;Ono, T., Denda, R., Tsukahara, Y., Nakamura, T., Okamoto, K., Takayanagi, H., &amp;amp; Nakashima, T. (2022). Simultaneous augmentation of muscle and bone by locomomimetism through calcium-PGC-1α signaling. Bone Research, 10(1), 52. PMID: 35918335 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345981/ PMC9345981] DOI: 10.1038/s41413-022-00225-w&amp;lt;/ref&amp;gt; show promise in counteracting frailty.&amp;lt;ref&amp;gt;Contartese, D., Di Sarno, L., Salamanna, F., Martini, L., Fini, M., Giavaresi, G., &amp;amp; Veronesi, F. (2023). Exploring In Vivo Models of Musculoskeletal Frailty: A Comprehensive Systematic Review. International Journal of Molecular Sciences, 24(23), 16948.  PMID: 38069274 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10706801/ PMC10706801] DOI: 10.3390/ijms242316948&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3160&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Prevention and treatment of frailty */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3160&amp;oldid=prev"/>
		<updated>2024-02-16T08:38:26Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Prevention and treatment of frailty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 08:38, 16 February 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l76&quot;&gt;Line 76:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 76:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Specialized-Oral Nutritional Supplement (S-ONS) - a specialized, nutrient-dense ready-to-drink liquid (Abbott Nutrition, Columbus, Ohio, USA) with per-serving (237 mL) contents of 350 kcal, 20 g protein, 11 g fat, 44 g carbohydrate, 1.5 g beta-hydroxy-beta-methylbutyrate (HMB) plus 160 IU vitamin D and other essential micronutrients - daily intake improved scores for mental health/cognition, vitality, social functioning, and general health in malnourished older adults.&amp;lt;ref&amp;gt;Baggs, G. E., Middleton, C., Nelson, J. L., Pereira, S. L., Hegazi, R. M., Matarese, L., ... &amp;amp; Deutz, N. (2023). Impact of a specialized oral nutritional supplement on quality of life in older adults following hospitalization: Post-hoc analysis of the NOURISH trial. Clinical Nutrition, 42(11), 2116-2123. PMID: 37757502  [https://doi.org/10.1016/j.clnu.2023.09.004 DOI: 10.1016/j.clnu.2023.09.004]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Specialized-Oral Nutritional Supplement (S-ONS) - a specialized, nutrient-dense ready-to-drink liquid (Abbott Nutrition, Columbus, Ohio, USA) with per-serving (237 mL) contents of 350 kcal, 20 g protein, 11 g fat, 44 g carbohydrate, 1.5 g beta-hydroxy-beta-methylbutyrate (HMB) plus 160 IU vitamin D and other essential micronutrients - daily intake improved scores for mental health/cognition, vitality, social functioning, and general health in malnourished older adults.&amp;lt;ref&amp;gt;Baggs, G. E., Middleton, C., Nelson, J. L., Pereira, S. L., Hegazi, R. M., Matarese, L., ... &amp;amp; Deutz, N. (2023). Impact of a specialized oral nutritional supplement on quality of life in older adults following hospitalization: Post-hoc analysis of the NOURISH trial. Clinical Nutrition, 42(11), 2116-2123. PMID: 37757502  [https://doi.org/10.1016/j.clnu.2023.09.004 DOI: 10.1016/j.clnu.2023.09.004]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;==== Preclinical development of treatment for frailty ====&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Some frailty treatments that have been evaluated in in vivo models for the effectiveness of &#039;&#039;&#039;alpha-ketoglutarate (AKG)&#039;&#039;&#039;,&amp;lt;ref&amp;gt;Shahmirzadi, A. A., Edgar, D., Liao, C. Y., Hsu, Y. M., Lucanic, M., Shahmirzadi, A. A., ... &amp;amp; Lithgow, G. J. (2020). Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. Cell metabolism, 32(3), 447-456. PMID: 32877690 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508957/ PMC8508957] DOI: 10.1016/j.cmet.2020.08.004&amp;lt;/ref&amp;gt; [[Isomyosamine|&#039;&#039;&#039;MyMD-1&#039;&#039;&#039;]] (&#039;&#039;&#039;Isomyosamine&#039;&#039;&#039;),&amp;lt;ref&amp;gt;[https://www.sec.gov/Archives/edgar/data/1321834/000149315222020346/ex99-1.htm The Phase 2 multi-center double-blind, placebo controlled, randomized study (NCT05283486]) investigates the efficacy, tolerability and pharmacokinetics of MYMD-1 in the treatment of chronic inflammation associated with sarcopenia/frailty in participants aged 65 years or older.&amp;lt;/ref&amp;gt; &#039;&#039;&#039;[[rapamycin]]&#039;&#039;&#039;, &#039;&#039;&#039;recombinant Sestrin 1 (rSESN1)&#039;&#039;&#039;,&amp;lt;ref&amp;gt;Jing, Y., Zuo, Y., Sun, L., Yu, Z. R., Ma, S., Hu, H., ... &amp;amp; Wang, S. (2023). SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Proliferation, e13455. PMID: 37199024 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212707/ PMC10212707] DOI: 10.1111/cpr.13455&amp;lt;/ref&amp;gt; and  an aminoindazole derivative, &#039;&#039;&#039;locamidazole (LAMZ)&#039;&#039;&#039;&amp;lt;ref&amp;gt;Ono, T., Denda, R., Tsukahara, Y., Nakamura, T., Okamoto, K., Takayanagi, H., &amp;amp; Nakashima, T. (2022). Simultaneous augmentation of muscle and bone by locomomimetism through calcium-PGC-1α signaling. Bone Research, 10(1), 52. PMID: 35918335 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345981/ PMC9345981] DOI: 10.1038/s41413-022-00225-w&amp;lt;/ref&amp;gt; show promise in counteracting frailty.&amp;lt;ref&amp;gt;Contartese, D., Di Sarno, L., Salamanna, F., Martini, L., Fini, M., Giavaresi, G., &amp;amp; Veronesi, F. (2023). Exploring In Vivo Models of Musculoskeletal Frailty: A Comprehensive Systematic Review. International Journal of Molecular Sciences, 24(23), 16948.  PMID: 38069274 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10706801/ PMC10706801] DOI: 10.3390/ijms242316948&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3154&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* References */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3154&amp;oldid=prev"/>
		<updated>2024-02-09T10:46:45Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;References&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:46, 9 February 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l93&quot;&gt;Line 93:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 93:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* &amp;#039;&amp;#039;&amp;#039;Compliant flooring&amp;#039;&amp;#039;&amp;#039; as a passive intervention approach designed to reduce the stiffness of the ground in order to attenuate the impact forces applied to the body in the event of a fall.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* &amp;#039;&amp;#039;&amp;#039;Compliant flooring&amp;#039;&amp;#039;&amp;#039; as a passive intervention approach designed to reduce the stiffness of the ground in order to attenuate the impact forces applied to the body in the event of a fall.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* &amp;#039;&amp;#039;&amp;#039;The raised, warm, soft, toilet seat&amp;#039;&amp;#039;&amp;#039; with adjustebl height and weight-bearing armrests allows for extended sitting without discomfort and that  can be used as a raised toilet seat/bedside commode/shower chair.&amp;lt;ref&amp;gt;[https://www.amazon.com/vdp/0dd81a192d2d45a48f22b3efcea4b0db The Ultimate Raised Toilet Seat, Voted 1 Most Comfortable]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* &amp;#039;&amp;#039;&amp;#039;The raised, warm, soft, toilet seat&amp;#039;&amp;#039;&amp;#039; with adjustebl height and weight-bearing armrests allows for extended sitting without discomfort and that  can be used as a raised toilet seat/bedside commode/shower chair.&amp;lt;ref&amp;gt;[https://www.amazon.com/vdp/0dd81a192d2d45a48f22b3efcea4b0db The Ultimate Raised Toilet Seat, Voted 1 Most Comfortable]&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== See also ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;* [[Intrinsic capacity]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Additional sources ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Additional sources ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;1. Rockwood K, et al. CMAJ. 2005;173:489–95.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;1. Rockwood K, et al. CMAJ. 2005;173:489–95.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3111&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Prevention and treatment of frailty */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=3111&amp;oldid=prev"/>
		<updated>2024-01-10T04:55:07Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Prevention and treatment of frailty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:55, 10 January 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l74&quot;&gt;Line 74:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 74:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Specialized-Oral Nutritional Supplement (S-ONS) - a specialized, nutrient-dense ready-to-drink liquid (Abbott Nutrition, Columbus, Ohio, USA) with per-serving (237 mL) contents of 350 kcal, 20 g protein, 11 g fat, 44 g carbohydrate, 1.5 g beta-hydroxy-beta-methylbutyrate (HMB) plus 160 IU vitamin D and other essential micronutrients - daily intake improved scores for mental health/cognition, vitality, social functioning, and general health in malnourished older adults.&amp;lt;ref&amp;gt;Baggs, G. E., Middleton, C., Nelson, J. L., Pereira, S. L., Hegazi, R. M., Matarese, L., ... &amp;amp; Deutz, N. (2023). Impact of a specialized oral nutritional supplement on quality of life in older adults following hospitalization: Post-hoc analysis of the NOURISH trial. Clinical Nutrition, 42(11), 2116-2123. PMID: 37757502  [https://doi.org/10.1016/j.clnu.2023.09.004 DOI: 10.1016/j.clnu.2023.09.004]&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==== Fall risks and how to reduce the likelihood of fall-induced injury ====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2988&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Comprehensive Geriatric Assessment (CGA) */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2988&amp;oldid=prev"/>
		<updated>2023-10-18T21:06:12Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Comprehensive Geriatric Assessment (CGA)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 21:06, 18 October 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l37&quot;&gt;Line 37:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 37:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;It is interesting to note that centenarians, as persons with an extraordinary adaptive capacity, benefit from exceptional biological reserves that might be underestimated by clinical appearances and may live with debilitating disease, but still present an advantage in terms of incident disability and death. Apparently, this is why their biological FI is significantly lower than the clinical FI&amp;lt;ref&amp;gt;Arosio, B., Geraci, A., Ferri, E., Mari, D., &amp;amp; Cesari, M. (2022). Biological Frailty Index in centenarians. Aging clinical and experimental research, 34(3), 687-690.  DOI: https://doi.org/10.1007/s40520-021-01993-x&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;It is interesting to note that centenarians, as persons with an extraordinary adaptive capacity, benefit from exceptional biological reserves that might be underestimated by clinical appearances and may live with debilitating disease, but still present an advantage in terms of incident disability and death. Apparently, this is why their biological FI is significantly lower than the clinical FI&amp;lt;ref&amp;gt;Arosio, B., Geraci, A., Ferri, E., Mari, D., &amp;amp; Cesari, M. (2022). Biological Frailty Index in centenarians. Aging clinical and experimental research, 34(3), 687-690.  DOI: https://doi.org/10.1007/s40520-021-01993-x&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;=== Using voice for frailty classification ===&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The possibility to estimate frailty value from voice, using a smartphone recording application, would make a breakthrough in frailty treatment. Voice is an emerging health indicator but has been scarcely studied in the context of frailty.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The following voice biomarkers were derived: &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;* peak and average volume, &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;* peak/average volume ratio, &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;* pauses’ total length, and pause length standard deviation.&amp;lt;ref&amp;gt;Lin, Y. C., Yan, H. T., Lin, C. H., &amp;amp; Chang, H. H. (2022). Predicting frailty in older adults using vocal biomarkers: a cross-sectional study. BMC geriatrics, 22(1), 549. PMID: 35778699 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248103/ PMC9248103] DOI: 10.1186/s12877-022-03237-7&amp;lt;/ref&amp;gt; &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The most-frail group had a higher peak volume/average volume ratio and greater variance in lengths of pauses between speech segments. These parameters indicate greater speech irregularity in the most-frail, compared to the less-frail. The most-frail group also had a longer total duration of pauses. Most-frail participants’ speech had different characteristics, compared to participants in the less-frail group.&amp;lt;ref&amp;gt;Rosen-Lang, Y., Zoubi, S., Cialic, R., &amp;amp; Orenstein, T. (2023). Using voice biomarkers for frailty classification. GeroScience, 1-5. PMID: 37480417 DOI: [https://doi.org/10.1007/s11357-023-00872-9 10.1007/s11357-023-00872-9]&amp;lt;/ref&amp;gt; It must be assumed that AI with machine learning on a large material will make it possible to accurately and quickly identify frailty and diagnose it.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Transitions in frailty phenotype states ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Transitions in frailty phenotype states ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2986&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Transitions in frailty phenotype states */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2986&amp;oldid=prev"/>
		<updated>2023-10-16T16:16:33Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Transitions in frailty phenotype states&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:16, 16 October 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l46&quot;&gt;Line 46:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 46:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Chronic muscle loss increases the risk of serious falls … and even death. However, it could be detected by &amp;#039;&amp;#039;&amp;#039;simple urine test &amp;quot;&amp;#039;&amp;#039;Myomar&amp;#039;&amp;#039;&amp;quot;&amp;#039;&amp;#039;&amp;#039; (similar to a home-pregnancy test) &amp;#039;&amp;#039;&amp;#039;designed for at-home monitoring of muscle loss&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref&amp;gt;[https://myomarmolecular.ca Myomar Molecular Inc.]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Chronic muscle loss increases the risk of serious falls … and even death. However, it could be detected by &amp;#039;&amp;#039;&amp;#039;simple urine test &amp;quot;&amp;#039;&amp;#039;Myomar&amp;#039;&amp;#039;&amp;quot;&amp;#039;&amp;#039;&amp;#039; (similar to a home-pregnancy test) &amp;#039;&amp;#039;&amp;#039;designed for at-home monitoring of muscle loss&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref&amp;gt;[https://myomarmolecular.ca Myomar Molecular Inc.]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;admmyomar@myomarmolecular.com 1344 Summer St Halifax, NS B3H4R2 Dalhousie University&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;admmyomar@myomarmolecular.com 1344 Summer St Halifax, NS B3H4R2 Dalhousie University&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Frailty Resilience Score (FRS) ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Aging can be viewed as a combination of three universal components: &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(i) depletion of limited body reserves (e.g., of stem, immune, muscle, neural cells, etc.), which poses limits to recovery; &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(ii) slowdown of physiological processes and responses to stress/damage, which delays the recovery with age; and &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(iii) inherently imperfect mechanisms of cell/tissue repair and cleaning, which result in incomplete recovery and damage accumulation over time. &amp;lt;ref name=&quot;key&quot; &amp;gt;Ukraintseva, S., Arbeev, K., Duan, M., Akushevich, I., Kulminski, A., Stallard, E., &amp;amp; Yashin, A. (2021). Decline in biological resilience as key manifestation of aging: Potential mechanisms and role in health and longevity. Mechanisms of ageing and development, 194, 111418. PMID: 33340523 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882032 PMC7882032] DOI: 10.1016/j.mad.2020.111418&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt; &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Identification of factors that contribute to frailty resilience is an important step in the development of effective therapies that protect against frailty.  Current literature lacks consensus on how to measure resilience. Having a better understanding of why some older adults can maintain relatively high function in the presence of organ impairments, and others do not, can help identify risk and protective factors and design targeted interventions to promote resilience. &amp;lt;ref name=&quot;key&quot; /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;A novel measure of frailty resilience, the &#039;&#039;&#039;Frailty Resilience Score (FRS)&#039;&#039;&#039;, was developed, that integrates frailty genetic risk, age, and sex. Application of this FRS to the LongGenity cohort demonstrated its validity and utility as a reliable predictor of overall survival.&amp;lt;ref&amp;gt;Milman, S., Lerman, B., Ayers, E., Zhang, Z., Sathyan, S., Levine, M., ... &amp;amp; Verghese, J. (2023). Frailty Resilience Score: A Novel Measure of Frailty Resilience Associated with Protection from Frailty and Survival. The Journals of Gerontology: Series A, glad138. PMC10562888 (available on 2024-05-29) https://doi.org/10.1093/gerona/glad138&amp;lt;/ref&amp;gt; FRS was used to identify a proteomic profile of frailty resilience.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Prevention and treatment of frailty ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Prevention and treatment of frailty ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2789&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* References */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2789&amp;oldid=prev"/>
		<updated>2023-06-15T20:33:30Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;References&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 20:33, 15 June 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l74&quot;&gt;Line 74:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 74:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Additional sources ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;1. Rockwood K, et al. CMAJ. 2005;173:489–95.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1503/cmaj.050051 PMID:16129869&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2. Gilbert T, et al. Lancet. 2018; 391:1775–82.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1016/S0140-6736(18)30668-8&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:29706364&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;3. Clegg A, et al. Age Ageing. 2016; 45:353–60.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1093/ageing/afw039&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:26944937&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Erratum in: Age Ageing. 2017; 45:353–60.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1093/ageing/afx001&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:28100452&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;4. Pajewski NM, et al. J Gerontol A Biol Sci Med Sci. 2019;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;74:1771–7.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1093/gerona/glz017&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:30668637&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;5. Mak JKL, et al. J Gerontol A Biol Sci Med Sci. 2022;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;77:2311–9.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1093/gerona/glac069&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:35303746&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;6. Mak JKL, et al. Gerontology. 2023;69:396–405.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1159/000527206&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:36450240&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;7. Johansson M, et al. BMJ. 2023; 380:e072953.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.1136/bmj-2022-072953&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:36596571&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;8. Sun X, et al. Aging (Albany NY). 2021; 13:7190–8.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https://doi.org/10.18632/aging.202576&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;PMID:33638946&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Main list]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Main list]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Age-related diseases]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Age-related diseases]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Longevity concepts]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Longevity concepts]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2766&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Fall risks and how to reduce the likelihood of fall-induced injury */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2766&amp;oldid=prev"/>
		<updated>2023-05-22T13:36:28Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Fall risks and how to reduce the likelihood of fall-induced injury&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 13:36, 22 May 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l66&quot;&gt;Line 66:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 66:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Medications.&amp;#039;&amp;#039;&amp;#039; Ones that affect cognition, coordination, and vision such as psychoactives, opiates, anticonvulsants, diuretics, laxatives, and sedatives.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Medications.&amp;#039;&amp;#039;&amp;#039; Ones that affect cognition, coordination, and vision such as psychoactives, opiates, anticonvulsants, diuretics, laxatives, and sedatives.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Improper use of assistive devices&amp;#039;&amp;#039;&amp;#039;.   Having a grab bar, cane or walker can become hazardous if not used precisely and in a coordinated manner.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Improper use of assistive devices&amp;#039;&amp;#039;&amp;#039;.   Having a grab bar, cane or walker can become hazardous if not used precisely and in a coordinated manner.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[File:Armchair with armrests.jpg.jpg|thumb|Armchair with armrests. Elevated, warm, padded toilet seat with height-adjustable and load-bearing armrests allows you to sit for long periods without discomfort and can be used not only as a raised toilet seat, but also as a bedside toilet or shower chair. If necessary, you can also insert a backrest.]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Technologies designed to reduce the likelihood of fall-induced injury:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Technologies designed to reduce the likelihood of fall-induced injury:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2764&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Prevention and treatment of frailty */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2764&amp;oldid=prev"/>
		<updated>2023-05-22T09:42:24Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Prevention and treatment of frailty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:42, 22 May 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l51&quot;&gt;Line 51:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 51:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Поручни в туалете.jpg|thumb|Handrails (grab bars) in the toilet  for  preventing seniors from having falls at home]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Поручни в туалете.jpg|thumb|Handrails (grab bars) in the toilet  for  preventing seniors from having falls at home]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Since an increased risk of fractures and falls leading to loss of mobility and increased hospitalizations is associated with a weakening of skeletal muscle and a decrease in their mass, the dietary supplement &#039;&#039;&#039;β-hydroxy β-methylbutyrate (beta-hydroxy-beta-methylbutyrate, HMB)&#039;&#039;&#039; with anabolic and anti-catabolic properties has been proposed for long-term use, as one of the means of preventing senile frailty in people over 65 years, &#039;&#039;&#039;particularly in bedridden or sedentary&#039;&#039;&#039;.&amp;lt;ref name=&quot;Rathmacher&quot;&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H. , Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 DOI: https://doi.org/10.1093/gerona/glaa218&amp;lt;/ref&amp;gt; Daily intake of 2-3 grams of this drug improves muscle quality and does not have pronounced side effects.&amp;lt;ref&amp;gt;Oktaviana, J., Zanker, J., Vogrin, S., &amp;amp; Duque, G. (2019). The effect of β-hydroxy-β-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons: a systematic review. The journal of nutrition, health &amp;amp; aging, 23(2), 145-150. PMID:30697623 DOI: https://doi.org/10.1007/s12603-018-1153-y&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Costa Riela NA, Alvim Guimarães MM, Oliveira de Almeida D, Araujo EMQ. (2021). [https://www.karger.com/Article/FullText/514236 Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Elderly Body Composition and Muscle Strength: A Review of Clinical Trials] [https://www.karger.com/Article/FullText/514236 Ann Nutr Metab].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Marshall&quot;&amp;gt; Marshall, R. N., Smeuninx, B., Morgan, P. T., &amp;amp; Breen, L. (2020). Nutritional strategies to offset disuse-induced skeletal muscle atrophy and anabolic resistance in older adults: From whole-foods to isolated ingredients. Nutrients, 12(5), 1533. PMID:32466126 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284346 DOI: https://doi.org/10.3390/nu12051533&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Davinelli&quot;&amp;gt;Davinelli, S., Corbi , G., &amp;amp; Scapagnini, G. (2021). Frailty syndrome: A target for functional nutrients?. Mechanisms of Aging and Development, 111441. PMID:33539905 DOI: https://doi.org/10.1016/j.mad.2021.111441&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Tamura&quot;&amp;gt;Tamura, Y., Omura, T., Toyoshima, K., &amp;amp; Araki, A. (2020). Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients, 12(11), 3367. PMID:33139628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693664 DOI: https://doi.org/10.3390/nu12113367&amp;lt;/ref&amp;gt; Since calcium β-hydroxy-β-methylbutyrate is less well absorbed by the body, it is advisable to use dietary supplements or high-protein foods to which β-hydroxy-β-methylbutyrate has been added, while calcium supplements to be given separately.&amp;lt;ref&amp;gt;Peng, LN., Cheng, YC., Yu, PC. et al. (2021). [https://link.springer.com/article/10.1007/s12603-021-1621-7 Oral Nutritional Supplement with β-hydroxy-β-methylbutyrate (HMB) Improves Nutrition, Physical Performance and Ameliorates Intramuscular Adiposity in Pre-Frail Older Adults: A Randomized Controlled Trial.] [https://link.springer.com/article/10.1007/s12603-021-1621-7 J Nutr Health Aging] doi: https://doi.org/10.1007/s12603-021-1621-7&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Since an increased risk of fractures and falls leading to loss of mobility and increased hospitalizations is associated with a weakening of skeletal muscle and a decrease in their mass, the dietary supplement &#039;&#039;&#039;β-hydroxy β-methylbutyrate (beta-hydroxy-beta-methylbutyrate, HMB)&#039;&#039;&#039; with anabolic and anti-catabolic properties has been proposed for long-term use, as one of the means of preventing senile frailty in people over 65 years, &#039;&#039;&#039;particularly in bedridden or sedentary&#039;&#039;&#039;.&amp;lt;ref name=&quot;Rathmacher&quot;&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H. , Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 DOI: https://doi.org/10.1093/gerona/glaa218&amp;lt;/ref&amp;gt; Daily intake of 2-3 grams of this drug improves muscle quality and does not have pronounced side effects.&amp;lt;ref&amp;gt;Oktaviana, J., Zanker, J., Vogrin, S., &amp;amp; Duque, G. (2019). The effect of β-hydroxy-β-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons: a systematic review. The journal of nutrition, health &amp;amp; aging, 23(2), 145-150. PMID:30697623 DOI: https://doi.org/10.1007/s12603-018-1153-y&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Costa Riela NA, Alvim Guimarães MM, Oliveira de Almeida D, Araujo EMQ. (2021). [https://www.karger.com/Article/FullText/514236 Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Elderly Body Composition and Muscle Strength: A Review of Clinical Trials] [https://www.karger.com/Article/FullText/514236 Ann Nutr Metab].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Marshall&quot;&amp;gt; Marshall, R. N., Smeuninx, B., Morgan, P. T., &amp;amp; Breen, L. (2020). Nutritional strategies to offset disuse-induced skeletal muscle atrophy and anabolic resistance in older adults: From whole-foods to isolated ingredients. Nutrients, 12(5), 1533. PMID:32466126 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284346 DOI: https://doi.org/10.3390/nu12051533&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Davinelli&quot;&amp;gt;Davinelli, S., Corbi , G., &amp;amp; Scapagnini, G. (2021). Frailty syndrome: A target for functional nutrients?. Mechanisms of Aging and Development, 111441. PMID:33539905 DOI: https://doi.org/10.1016/j.mad.2021.111441&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Tamura&quot;&amp;gt;Tamura, Y., Omura, T., Toyoshima, K., &amp;amp; Araki, A. (2020). Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients, 12(11), 3367. PMID:33139628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693664 DOI: https://doi.org/10.3390/nu12113367&amp;lt;/ref&amp;gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;In older adults with sarcopenia, HMB significantly enhance the effect of resistance exercise training on muscle strength, physical performance, muscle quality, and reduced inflammatory factors.&amp;lt;ref&amp;gt;Yang, C., Song, Y., Li, T., Chen, X., Zhou, J., Pan, Q., ... &amp;amp; Jia, H. (2023). Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study. The journal of nutrition, health &amp;amp; aging, 1-11. https://doi.org/10.1007/s12603-023-1911-1&amp;lt;/ref&amp;gt; According to preclinical studies in rodents, HMB may also improve learning and working memory.&amp;lt;ref&amp;gt;Munroe, M., Mahmassani, Z. S., Dvoretskiy, S., Reid, J. J., Miller, B. F., Hamilton, K., ... &amp;amp; Boppart, M. D. (2020). Cognitive function is preserved in aged mice following long-term β-hydroxy β-methylbutyrate supplementation. Nutritional Neuroscience, 23(3), 170-182. PMID: 29914347 DOI: 10.1080/1028415X.2018.1483101&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Barranco Pérez, A., García, L., Rueda, R., &amp;amp; Ramírez, M. (2022). Effects of beta-Hydroxy beta-Methylbutyrate Supplementation on Working Memory and Hippocampal Long-Term Potentiation in Rodents. Nutrients, 14(5):1090. PMID: 35268065 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912805 DOI: 10.3390/nu14051090&amp;lt;/ref&amp;gt;  &lt;/ins&gt;Since calcium β-hydroxy-β-methylbutyrate is less well absorbed by the body, it is advisable to use dietary supplements or high-protein foods to which β-hydroxy-β-methylbutyrate has been added, while calcium supplements to be given separately.&amp;lt;ref&amp;gt;Peng, LN., Cheng, YC., Yu, PC. et al. (2021). [https://link.springer.com/article/10.1007/s12603-021-1621-7 Oral Nutritional Supplement with β-hydroxy-β-methylbutyrate (HMB) Improves Nutrition, Physical Performance and Ameliorates Intramuscular Adiposity in Pre-Frail Older Adults: A Randomized Controlled Trial.] [https://link.springer.com/article/10.1007/s12603-021-1621-7 J Nutr Health Aging] doi: https://doi.org/10.1007/s12603-021-1621-7&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2763&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: /* Prevention and treatment of frailty */</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Frailty&amp;diff=2763&amp;oldid=prev"/>
		<updated>2023-05-22T08:35:28Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Prevention and treatment of frailty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 08:35, 22 May 2023&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l51&quot;&gt;Line 51:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 51:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Поручни в туалете.jpg|thumb|Handrails (grab bars) in the toilet  for  preventing seniors from having falls at home]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Поручни в туалете.jpg|thumb|Handrails (grab bars) in the toilet  for  preventing seniors from having falls at home]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Since an increased risk of fractures and falls leading to loss of mobility and increased hospitalizations is associated with a weakening of skeletal muscle and a decrease in their mass, the dietary supplement &#039;&#039;&#039;beta-hydroxy-beta-methylbutyrate &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(&lt;/del&gt;HMB)&#039;&#039;&#039; with anabolic and anti-catabolic properties has been proposed for long-term use, as one of the means of preventing senile frailty in people over 65 years, &#039;&#039;&#039;particularly in bedridden or sedentary&#039;&#039;&#039;.&amp;lt;ref name=&quot;Rathmacher&quot;&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H. , Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 DOI: https://doi.org/10.1093/gerona/glaa218&amp;lt;/ref&amp;gt; Daily intake of 2-3 grams of this drug improves muscle quality and does not have pronounced side effects.&amp;lt;ref&amp;gt;Oktaviana, J., Zanker, J., Vogrin, S., &amp;amp; Duque, G. (2019). The effect of β-hydroxy-β-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons: a systematic review. The journal of nutrition, health &amp;amp; aging, 23(2), 145-150. PMID:30697623 DOI: https://doi.org/10.1007/s12603-018-1153-y&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Costa Riela NA, Alvim Guimarães MM, Oliveira de Almeida D, Araujo EMQ. (2021). [https://www.karger.com/Article/FullText/514236 Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Elderly Body Composition and Muscle Strength: A Review of Clinical Trials] [https://www.karger.com/Article/FullText/514236 Ann Nutr Metab].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Marshall&quot;&amp;gt; Marshall, R. N., Smeuninx, B., Morgan, P. T., &amp;amp; Breen, L. (2020). Nutritional strategies to offset disuse-induced skeletal muscle atrophy and anabolic resistance in older adults: From whole-foods to isolated ingredients. Nutrients, 12(5), 1533. PMID:32466126 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284346 DOI: https://doi.org/10.3390/nu12051533&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Davinelli&quot;&amp;gt;Davinelli, S., Corbi , G., &amp;amp; Scapagnini, G. (2021). Frailty syndrome: A target for functional nutrients?. Mechanisms of Aging and Development, 111441. PMID:33539905 DOI: https://doi.org/10.1016/j.mad.2021.111441&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Tamura&quot;&amp;gt;Tamura, Y., Omura, T., Toyoshima, K., &amp;amp; Araki, A. (2020). Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients, 12(11), 3367. PMID:33139628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693664 DOI: https://doi.org/10.3390/nu12113367&amp;lt;/ref&amp;gt; Since calcium β-hydroxy-β-methylbutyrate is less well absorbed by the body, it is advisable to use dietary supplements or high-protein foods to which β-hydroxy-β-methylbutyrate has been added, while calcium supplements to be given separately.&amp;lt;ref&amp;gt;Peng, LN., Cheng, YC., Yu, PC. et al. (2021). [https://link.springer.com/article/10.1007/s12603-021-1621-7 Oral Nutritional Supplement with β-hydroxy-β-methylbutyrate (HMB) Improves Nutrition, Physical Performance and Ameliorates Intramuscular Adiposity in Pre-Frail Older Adults: A Randomized Controlled Trial.] [https://link.springer.com/article/10.1007/s12603-021-1621-7 J Nutr Health Aging] doi: https://doi.org/10.1007/s12603-021-1621-7&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Since an increased risk of fractures and falls leading to loss of mobility and increased hospitalizations is associated with a weakening of skeletal muscle and a decrease in their mass, the dietary supplement &#039;&#039;&#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;β-hydroxy β-methylbutyrate (&lt;/ins&gt;beta-hydroxy-beta-methylbutyrate&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;HMB)&#039;&#039;&#039; with anabolic and anti-catabolic properties has been proposed for long-term use, as one of the means of preventing senile frailty in people over 65 years, &#039;&#039;&#039;particularly in bedridden or sedentary&#039;&#039;&#039;.&amp;lt;ref name=&quot;Rathmacher&quot;&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H. , Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 DOI: https://doi.org/10.1093/gerona/glaa218&amp;lt;/ref&amp;gt; Daily intake of 2-3 grams of this drug improves muscle quality and does not have pronounced side effects.&amp;lt;ref&amp;gt;Oktaviana, J., Zanker, J., Vogrin, S., &amp;amp; Duque, G. (2019). The effect of β-hydroxy-β-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons: a systematic review. The journal of nutrition, health &amp;amp; aging, 23(2), 145-150. PMID:30697623 DOI: https://doi.org/10.1007/s12603-018-1153-y&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Costa Riela NA, Alvim Guimarães MM, Oliveira de Almeida D, Araujo EMQ. (2021). [https://www.karger.com/Article/FullText/514236 Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Elderly Body Composition and Muscle Strength: A Review of Clinical Trials] [https://www.karger.com/Article/FullText/514236 Ann Nutr Metab].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Marshall&quot;&amp;gt; Marshall, R. N., Smeuninx, B., Morgan, P. T., &amp;amp; Breen, L. (2020). Nutritional strategies to offset disuse-induced skeletal muscle atrophy and anabolic resistance in older adults: From whole-foods to isolated ingredients. Nutrients, 12(5), 1533. PMID:32466126 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284346 DOI: https://doi.org/10.3390/nu12051533&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Davinelli&quot;&amp;gt;Davinelli, S., Corbi , G., &amp;amp; Scapagnini, G. (2021). Frailty syndrome: A target for functional nutrients?. Mechanisms of Aging and Development, 111441. PMID:33539905 DOI: https://doi.org/10.1016/j.mad.2021.111441&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;Tamura&quot;&amp;gt;Tamura, Y., Omura, T., Toyoshima, K., &amp;amp; Araki, A. (2020). Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty. Nutrients, 12(11), 3367. PMID:33139628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693664 DOI: https://doi.org/10.3390/nu12113367&amp;lt;/ref&amp;gt; Since calcium β-hydroxy-β-methylbutyrate is less well absorbed by the body, it is advisable to use dietary supplements or high-protein foods to which β-hydroxy-β-methylbutyrate has been added, while calcium supplements to be given separately.&amp;lt;ref&amp;gt;Peng, LN., Cheng, YC., Yu, PC. et al. (2021). [https://link.springer.com/article/10.1007/s12603-021-1621-7 Oral Nutritional Supplement with β-hydroxy-β-methylbutyrate (HMB) Improves Nutrition, Physical Performance and Ameliorates Intramuscular Adiposity in Pre-Frail Older Adults: A Randomized Controlled Trial.] [https://link.springer.com/article/10.1007/s12603-021-1621-7 J Nutr Health Aging] doi: https://doi.org/10.1007/s12603-021-1621-7&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Cholecalciferol (vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;) deficiency has been identified as a risk factor for accelerated muscle loss, poor physical performance and falls.&amp;lt;ref&amp;gt;Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., ... &amp;amp; Nussler, A. K. (2016). Crucial role of vitamin D in the musculoskeletal system. Nutrients, 8(6), 319. PMID:27258303 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924160 DOI: https://doi.org/10.3390/nu8060319&amp;lt;/ref&amp;gt; Therefore, it is recommended that those patients with vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; levels below 30 ng/ml also take for three months vitamin D&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; capsules (1000-2000 IU/day divided into two doses) or until its serum level reaches a sufficient range (30-60 ng/ml).&amp;lt;ref&amp;gt;Rathmacher, J. A., Pitchford, L. M., Khoo, P., Angus, H., Lang, J., Lowry, K., ... &amp;amp; Sharp, R. L. (2020). Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study. The Journals of Gerontology: Series A, 75(11), 2089-2097. PMID:32857128 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566440 doi: https://doi.org/10.1093/gerona/glaa218 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
</feed>